Showing 1 - 17 results of 17 for search 'Zhixu He', query time: 0.03s
Refine Results
-
1
-
2
-
3
CSF3R as a potential prognostic biomarker and immunotherapy target in glioma by Minglei Huang, Longze Zhang, Yan Wu, Xue Zhou, Yanyang Wang, Jidong Zhang, Ye Liu, Zhixu He, Xianyao Wang
Published 2024-06-01Get full text
Article -
4
Identification and validation of ARF6 for a potential prognostic biomarker of acute myeloid leukemia by Chike Zhang, Yang Liu, Xiaoshuang Yuan, Xu Yang, Bo Yang, Yi Huang, Feiqing Wang, Zhixu He, Yanju Li
Published 2025-06-01Get full text
Article -
5
-
6
Parabacteroides as a promising target for disease intervention: current stage and pending issues by Jing Liu, Hui Qiu, Jiamin Zhao, Nan Shao, Chao Chen, Zhixu He, Xu Zhao, Juanjuan Zhao, Ya Zhou, Lin Xu
Published 2025-07-01Get full text
Article -
7
Risk analysis of cardiovascular toxicity in patients with lymphoma treated with CD19 CAR T cells by Yang Liu, Xiaoshuang Yuan, Xu Yang, Bo Yang, Guangyang Liu, Xiao Xu, Sanbin Wang, Zhixu He, Feiqing Wang, Yanju Li
Published 2025-01-01Get full text
Article -
8
Integrated Multiomics Analysis and Machine Learning Approaches in Bladder Cancer: Unveiling the Impact of Immunogenic Cell Death and Its Key Gene SLC2A3 on Prognosis and Personaliz... by Mouyuan Sun, Quanjie Zhang, Zhixu He, Yaxian Luo, Yan Tu, Lianjie Peng, Huchao Mao, Jingyu Zhang, Tao Qiu, Yan Zhang
Published 2025-06-01Get full text
Article -
9
Approved trends and product characteristics of digital therapeutics in four countries by Jun Liang, Qichuan Fang, Xiaoyi Jiao, Peng Xiang, Junhao Ma, Zijiao Zhang, Yongcheng Liu, Yunfan He, Yingjun Li, Zhixu He, Jianbo Lei
Published 2025-05-01Get full text
Article -
10
Integrated microfluidics-based construction of anti-BTN2A2 gel droplet cell preparations for non-invasive tumor-infiltrating lymphocyte therapy by Yishen Tian, Jingxuan Li, Na Yang, Yang Zhao, Jiancao Zuo, Hang Xiong, Yiwen Pan, Li Xiao, Min Su, Feng Han, Zhixu He, Rong Hu
Published 2025-04-01Get full text
Article -
11
hAMSCs regulate EMT in the progression of experimental pulmonary fibrosis through delivering miR-181a-5p targeting TGFBR1 by Yanyang Wang, Chan Liu, Nuoxin Wang, Dong Weng, Yan Zhao, Hongyu Yang, Haoyuan Wang, Shangfu Xu, Jianmei Gao, Changhui Lang, Zhenhai Fan, Limei Yu, Zhixu He
Published 2025-01-01Get full text
Article -
12
Efficacy of maintenance or consolidation therapy for multiple myeloma based on proteasome inhibitors: a meta-analysis by Dan Wu, Feiqing Wang, Xu Yang, Bo Yang, Juan Chen, Jinyang Cheng, Bo Wei, Xiaoshuang Yuan, Tingting Tian, Zhenhua Liu, Zhixu He, Yang Liu, Yanju Li
Published 2025-04-01Get full text
Article -
13
MAPK4 inhibits the early aberrant activation of B cells in rheumatoid arthritis by promoting the IRF4-SHIP1 signaling pathway by Pei Huang, Guangli Yang, Pingping Zhang, Yin Zhu, Yaning Guan, Jian Sun, Qian Li, Yang An, Xiaoqi Shi, Juanjuan Zhao, Chaohong Liu, Zhixu He, Yan Chen, Zuochen Du
Published 2025-01-01Get full text
Article -
14
Efficacy and safety of chimeric antigen receptor T cells targeting BCMA and GPRC5D in relapsed or refractory multiple myeloma by Xu Yang, Feiqing Wang, Feiqing Wang, Xiaoshuang Yuan, Bo Yang, Juan Chen, Jinyang Cheng, Guangyang Liu, Dongxin Tang, Xiao Xu, Sanbin Wang, Zhixu He, Yang Liu, Yanju Li
Published 2024-12-01Get full text
Article -
15
Efficacy and safety of CD19 combined with CD22 or CD20 chimeric antigen receptor T-cell therapy for hematological malignancies by Xiaoshuang Yuan, Feiqing Wang, Feiqing Wang, Peng Zhao, Bo Yang, Xu Yang, Ting Tian, Bingbing Li, Guangyang Liu, Sanbin Wang, Dongxin Tang, Zhixu He, Yanju Li, Yang Liu
Published 2025-05-01Get full text
Article -
16
Baicalin: a potential therapeutic agent for acute kidney injury and renal fibrosis by Xiaoming Li, Xiaoming Li, Rui Xu, Rui Xu, Dan Zhang, Ji Cai, Ji Cai, He Zhou, He Zhou, Tao Song, Tao Song, Xianyao Wang, Xianyao Wang, Qinghong Kong, Liujin Li, Zhaohui Liu, Zhixu He, Zhengzhen Tang, Jun Tan, Jidong Zhang, Jidong Zhang, Jidong Zhang
Published 2025-01-01Get full text
Article -
17
The RBM39 degrader indisulam inhibits acute megakaryoblastic leukemia by altering the alternative splicing of ZMYND8 by Ying Yang, Zhiheng Li, Yang Yang, Peifang Xiao, Zhixu He, Zimu Zhang, Yizhen Li, Lei Shi, Xiaodong Wang, Yanfang Tao, Junjie Fan, Fenli Zhang, Chunxia Yang, Fahua Yao, Tongting Ji, Yongping Zhang, Bi Zhou, Juanjuan Yu, Ailian Guo, Zhongling Wei, Wanyan Jiao, Yumeng Wu, Yan Li, Di Wu, Yijun Wu, Li Gao, Yixin Hu, Jian Pan, Shaoyan Hu, Xiaoyan Yang
Published 2025-04-01Get full text
Article